NIH-funded research R01 grant

How immune cells and cocaine affect the brain's protective barrier in people with HIV

Official title: Immune mechanisms that shape the blood brain barrier in people living with HIV and cocaine use disorder

Funded at Johns Hopkins University · NIH-11306608 · Data updated 2026-11-12

The team will look at whether past or current cocaine use changes immune cells and weakens the blood-brain barrier in people living with HIV.

More Cocaine Use Disorder research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJune 1, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$1,026,430
NIH project number5R01DA060568-03
Project IDNIH-11306608 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV, especially those with a history of cocaine use, who can give blood samples and complete cognitive testing are ideal candidates.

Less likely to help

People without HIV or whose cognitive issues are caused by unrelated conditions (such as stroke or advanced Alzheimer's disease) are unlikely to benefit directly from this project.

What this research studies

If you join, researchers will compare people living with HIV who have and haven't used cocaine by collecting blood samples and doing brief cognitive tests. They will look for a specific kind of immune cell (CCR2+ALCAM+ intermediate monocytes) that may carry HIV into the brain and check whether those cells cross the blood-brain barrier more easily. Laboratory models of the barrier will be used to see how these cells and cocaine affect barrier cells and tight junctions. The aim is to connect immune changes and barrier damage to brain viral reservoirs and thinking problems.

Why it matters

Potential benefit: If successful, this work could point to ways to protect the brain and improve thinking and memory for people with HIV who have used cocaine.

How similar studies have gone: Prior research has linked cocaine and HIV to blood-brain barrier damage and cognitive issues, but targeting CCR2+ALCAM+ monocytes as a route into the brain is a newer approach.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Veenhuis, Rebecca Terilli — Johns Hopkins University
  • Study coordinator: Veenhuis, Rebecca Terilli

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.